Zurit Levine - 24 Apr 2026 Form 4 Insider Report for COMPUGEN LTD (CGEN)

Reporting relationship: SVP, Business Development
Issuer ticker: CGEN
Reported as of: 24 Apr 2026
Net transaction value: -$6,400
SEC form: 4
Accepted by SEC: 27 Apr 2026, 16:03:18 UTC
Prior SEC filing: 15 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Zurit Levine

Key filing fact

Zurit Levine filed Form 4 for COMPUGEN LTD (CGEN) on 27 Apr 2026.

Key facts

This page summarizes Zurit Levine's Form 4 filing for COMPUGEN LTD (CGEN).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 27 Apr 2026, 16:03.

Change

Previous filing in this sequence was filed on 15 Apr 2026.
Current net transaction value: -$6,400.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001972527 Primary reporting owner

Levine Zurit

Relationship: SVP, Business Development
Address: C/O COMPUGEN LTD., 26 HAROKMIM STREET, HOLON, ISRAEL
Signature: /s/ Zurit Levine
Signature date: 27 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CGEN transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +2,000
Change %: +6.8%
Price: $1.15^*
Shares after: 31,375
Date: 24 Apr 2026
Ownership: Direct
Footnotes: F1

CGEN transaction

Ordinary Shares

Sale

Transaction value: $6,400
Shares: -2,000
Change %: -6.4%
Price: $3.20
Shares after: 29,375
Date: 24 Apr 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CGEN transaction Derivative

Share Option (right to buy)

Options Exercise

Transaction value
Shares: -2,000
Change %: -3.7%
Price: $0.000000^*
Shares after: 52,000
Date: 24 Apr 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 2,000
Exercise price: $1.15
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.

Footnote F2

This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.